易方达生物医药_Providing professional financial news and data related to 易方达生物医药, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
VGT (02476.HK): Internal Equity Restructuring of Controlling Shareholder's Upper-Level Shareholders; Control Unchanged
Finance
ANGANG STEEL (00347.HK): Proposes Registration of Debt Financing Instruments of up to RMB 10 Billion
Finance
HUTCHMED (00013.HK): ATLED (Fanregratinib) Approved by NMPA for FGFR2 Fusion Cholangiocarcinoma
Finance
ZIJIN MINING (02899.HK): Donates RMB 10 Million to Disaster-Stricken Area in Gyirong, Tibet
Finance
ANTON OILFIELD (03337.HK): Grants 2.09 Million Restricted Shares to 8 Employees
Finance
CH DREDG ENV (00871.HK): Expects H1 Loss to Widen to Approximately RMB 40.7 Million
Finance
JINYAN KAOLIN (02693.HK): Enters Engineering Procurement Contract with Connected Party for RMB 7 Million
Finance
Medcaptain Medical (02041.HK): Global Offering at HKD 15.42 Per Share, Listing Expected on 7 September
Finance
E-HOUSE ENT (02048.HK): Restructuring Schemes Approved by Overwhelming Majority of Scheme Creditors
Finance
LI NING (02331.HK): Grants Approximately 12.6 Million Share Options at HKD 13.90 Per Share

Scan QR Code

Download App